← Back to Patent Explorer
US4752470A Expired / Lapsed US ⏱️ 0.0 years remaining

Controlled release indomethacin

Assignee: NORTEC DEVELOPMENT ASSOCIATES Inc (NORTEC) A CORP OF NEW JERSEY
•
Filing: 1986-11-24
•
Granted: 1988-06-21
•
Expires: 2006-11-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In accordance with the present invention, the controlled release formulation contains coated pellets of indomethacin of only one type. The pellet releases indomethacin in both immediate and sustained release form. The immediate release indomethacin is rapidly absorbed from the stomach to provide a bolus dose of active agent. The sustained release indomethacin is gradually released over time to maintain the blood levels at effective concentrations for long periods of time.

Inventors

  • 👤 Atul M. Mehta

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 06:01
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61K31/403; A61K31/404; A61K31/405; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 88 words
An indomethacin controlled release formulation consisting essentially of: (a) one type of indomethacin containing pellet one which exhibits both immediate release and sustained release characteristics comprising (1) a non-pareil pellet; (2) a first coating comprised of about 5% to about 30% by weight of said pellet and first coating of indomethacin and about 2% to 10% by weight of a binding agent; and (3) A second coating comprised of a mixture of ethyl cellulose and hydroxypropyl cellulose in a weight ratio range of about 50:50 to about 90:10.
Claim 2
Dependent Claim 88 words
An indomethacin controlled release formulation consisting essentially of: (a) one type of indomethacin containing pellet one which exhibits both immediate release and sustained release characteristics comprising (1) a non-pareil pellet; (2) a first coating comprised of about 5% to about 30% by weight of said pellet and first coating of indomethacin and about 2% to 10% by weight of a binding agent; and (3) A second coating comprised of a mixture of ethyl cellulose and hydroxypropyl cellulose in a weight ratio range of about 50:50 to about 90:10.
Claim 3
Dependent Claim 23 words
The formulation according to claim 1 wherein said binding agent comprises about 3% to 4% by weight of said pellet and first coating.
Claim 4
Dependent Claim 30 words
The formulation according to claim 1 wherein said mixture of ethyl cellulose and hydroxypropyl cellulose comprises about 2% to about 5% of the weight of said pellet and first coating.
Claim 5
Dependent Claim 25 words
The formulation according to claim 2 wherein said binding agent is selected from the group consisting of hydroxypropylmethyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose and polyvinylpyrrolidone.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-06-21 1991-12-21 1992-06-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-06-21 1995-12-21 1996-06-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-06-21 1999-12-21 2000-06-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag